These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34856682)

  • 41. Neonatal cholestasis. New approaches to diagnostic evaluation and therapy.
    Shah HA; Spivak W
    Pediatr Clin North Am; 1994 Oct; 41(5):943-66. PubMed ID: 7936782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dialogs in the assessment of neonatal cholestatic liver disease.
    Cho SJ; Perito ER; Shafizadeh N; Kim GE
    Hum Pathol; 2021 Jun; 112():102-115. PubMed ID: 33359238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A shift in paradigm towards human biology-based systems for cholestatic-liver diseases.
    Noor F
    J Physiol; 2015 Dec; 593(23):5043-55. PubMed ID: 26417843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endo-hepatology: a new paradigm.
    Chang KJ; Samarasena JB; Iwashita T; Nakai Y; Lee JG
    Gastrointest Endosc Clin N Am; 2012 Apr; 22(2):379-85, xi. PubMed ID: 22632959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.
    Palmer M; Regev A; Lindor K; Avigan MI; Dimick-Santos L; Treem W; Marcinak JF; Lewis JH; Anania FA; Seekins D; Shneider BL; Chalasani N
    Aliment Pharmacol Ther; 2020 Jan; 51(1):90-109. PubMed ID: 31762074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current and near-future progress (and regress) within hepatology. The Danish Society of Hepatology].
    Ugeskr Laeger; 2001 Mar; 163(12):1697. PubMed ID: 11284397
    [No Abstract]   [Full Text] [Related]  

  • 47. [Consensus on secondary prevention of primary liver cancer (2021 version)].
    Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2021 Mar; 29(3):216-226. PubMed ID: 33902188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations.
    Buscarini E; Plauchu H; Garcia Tsao G; White RI; Sabbà C; Miller F; Saurin JC; Pelage JP; Lesca G; Marion MJ; Perna A; Faughnan ME
    Liver Int; 2006 Nov; 26(9):1040-6. PubMed ID: 17032403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
    Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
    Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pathophysiology and therapy of pruritus in cholestatic liver diseases].
    Schachschal G; Schmidt H
    Z Gastroenterol; 2003 Jun; 41(6):627. PubMed ID: 12806549
    [No Abstract]   [Full Text] [Related]  

  • 51. [Management of pruritus in patients with cholestatic liver disease].
    Kremer AE; Kraus MR
    MMW Fortschr Med; 2016 Jun; 158(12):64-7. PubMed ID: 27324009
    [No Abstract]   [Full Text] [Related]  

  • 52. [Recommendations for clinicopathologic quality standards in gastroenterology and hepatology. Consensus report of the Austrian Society of Gastroenterology ahd Hepatology and the Austrian Society of Pathology].
    Wrba F; Renner F
    Z Gastroenterol; 1998 Oct; 36(10):917-23. PubMed ID: 9846371
    [No Abstract]   [Full Text] [Related]  

  • 53. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.
    Cong WM; Bu H; Chen J; Dong H; Zhu YY; Feng LH; Chen J;
    World J Gastroenterol; 2016 Nov; 22(42):9279-9287. PubMed ID: 27895416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oesophageal and scaly skin lesions associated with chronic cholestatic liver disease.
    Kasper P; Goeser T; Nierhoff D
    Gut; 2019 Nov; 68(11):1960-2018. PubMed ID: 30878948
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hepatology 2009].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1335-9. PubMed ID: 19517326
    [No Abstract]   [Full Text] [Related]  

  • 56. [Chinese guidelines on the management of liver cirrhosis].
    Chinese Society of Hepatology,Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):846-865. PubMed ID: 31941240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Idiopathic hypereosinophilic syndrome presenting as cholestatic liver disease.
    Valente AI; Pinto HC; Ramalho F; Cabrita PF; Catarino C; Serejo F; Baptista A; Saragoça A; Bordalo O; Moura MC
    Eur J Gastroenterol Hepatol; 1997 Aug; 9(8):815-7. PubMed ID: 9282282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Chronic cholestatic liver diseases : Differential diagnosis, pathogenesis and current treatment in adults].
    Hohenester S; Beuers U
    Internist (Berl); 2017 Aug; 58(8):805-825. PubMed ID: 28721532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021).
    You H; Duan W; Li S; Lv T; Chen S; Lu L; Ma X; Han Y; Nan Y; Xu X; Duan Z; Wei L; Jia J; Zhuang H;
    J Clin Transl Hepatol; 2023 Jun; 11(3):736-746. PubMed ID: 36969891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An update on the physiopathology and therapeutic management of cholestatic pruritus in children.
    Thébaut A; Debray D; Gonzales E
    Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):103-109. PubMed ID: 29031874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.